Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tor

Showing results (151-160 of 155) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 155 results.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1995
Prospective study of drug-resistant tuberculosis in a Spanish urban population including patients at risk for HIV infectionV Ausina, N Riutort, B Viñado, et al.
Medicina Clinica|May 23, 1992
[Multicenter study of the prevalence of type 2 human immunodeficiency virus infection in Spain (1990)]V Soriano, I Aguado, J L Fernández, et al.
Journal of Viral Hepatitis|March 5, 2003
Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patientsC Tural, D Fuster, J Tor, et al.
HIV Medicine|November 20, 2013
Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baselineR Sanmartín, J Tor, A Sanvisens, et al.
Clinical Pharmacology and Therapeutics|September 1, 1990
Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acidR H Levy, A W Rettenmeier, G D Anderson, et al.
Pageof 16

Showing results (151-160 of 155) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 155 results.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1995
Prospective study of drug-resistant tuberculosis in a Spanish urban population including patients at risk for HIV infectionV Ausina, N Riutort, B Viñado, et al.
Medicina Clinica|May 23, 1992
[Multicenter study of the prevalence of type 2 human immunodeficiency virus infection in Spain (1990)]V Soriano, I Aguado, J L Fernández, et al.
Journal of Viral Hepatitis|March 5, 2003
Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patientsC Tural, D Fuster, J Tor, et al.
HIV Medicine|November 20, 2013
Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baselineR Sanmartín, J Tor, A Sanvisens, et al.
Clinical Pharmacology and Therapeutics|September 1, 1990
Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acidR H Levy, A W Rettenmeier, G D Anderson, et al.
Pageof 16